Standard Initiating Dose of Lantus (Insulin Glargine)
For type 2 diabetes patients who are insulin-naive, start Lantus at 0.2 units/kg or up to 10 units once daily, administered at the same time each day. 1
Type 2 Diabetes Starting Dose
The FDA-approved dosing for insulin-naive type 2 diabetes patients is straightforward:
- Primary recommendation: 0.2 units/kg body weight OR up to 10 units once daily 1
- The American Diabetes Association guidelines support a starting range of 0.1-0.2 units/kg/day 2, 3, 4
- For a typical 50 kg patient, this translates to approximately 10 units once daily 4
Lantus should be administered subcutaneously once daily at any time of day, but consistently at the same time every day. 1
Dose Titration Algorithm
After initiation, systematic uptitration is essential to reach glycemic targets:
- Increase by 2-4 units every 3-4 days until fasting blood glucose reaches target range (80-130 mg/dL) 2, 3, 4
- More specifically:
- Alternative approach: increase by 10-15% of current dose once or twice weekly 4
Type 1 Diabetes Starting Dose
For type 1 diabetes, the approach differs significantly:
- Start with approximately one-third of total daily insulin requirements as basal insulin 1
- Total daily insulin requirements typically range from 0.4-1.0 units/kg/day, with 0.5 units/kg/day being typical for metabolically stable patients 3, 4
- The remaining two-thirds should be provided as short-acting, premeal insulin 1
- Higher doses (approaching 1.0 units/kg/day) may be required immediately following diabetic ketoacidosis 3
Special Considerations and Common Pitfalls
When to Use Higher Starting Doses
Consider more aggressive initial dosing in type 2 diabetes patients with:
- HbA1c ≥9% 4
- Blood glucose levels ≥300-350 mg/dL 4
- HbA1c 10-12% with symptomatic or catabolic features 4
In these cases, consider starting with 0.3-0.4 units/kg/day or a basal-bolus regimen from the outset 4.
Critical Pitfall: Overbasalization
Be vigilant for overbasalization when basal insulin exceeds 0.5 units/kg/day 2, 4:
- Clinical signals include:
When basal insulin approaches 0.5-1.0 units/kg/day and A1C remains elevated despite controlled fasting glucose, add prandial insulin rather than continuing to escalate basal insulin 2, 4.
Administration Details
- Inject subcutaneously into the abdominal area, thigh, or deltoid 1
- Rotate injection sites within the same region to reduce risk of lipodystrophy 1
- Never administer intravenously or via insulin pump 1
- Do not dilute or mix with any other insulin or solution 1
Monitoring Requirements
- Daily fasting blood glucose monitoring is essential during titration 4
- Increase frequency of blood glucose monitoring during any insulin regimen changes 1
- Reassess every 3 days during active titration and every 3-6 months once stable 4
Switching from Other Insulins
When transitioning to Lantus from other basal insulins 1:
- From once-daily NPH: use the same dose
- From twice-daily NPH: use 80% of total NPH dose
- From TOUJEO (U-300 glargine): use 80% of TOUJEO dose